Lynne Laube - Nov 5, 2021 Form 4 Insider Report for Cardlytics, Inc. (CDLX)

Role
Chief Executive Officer, Director
Signature
/s/ Kirk Somers, Attorney-in-Fact
Stock symbol
CDLX
Transactions as of
Nov 5, 2021
Transactions value $
-$1,176,582
Form type
4
Date filed
11/8/2021, 04:29 PM
Previous filing
Nov 3, 2021
Next filing
Dec 13, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CDLX Common Stock Sale -$963K -10.7K -3.17% $90.23* 326K Nov 5, 2021 Direct F1, F2
transaction CDLX Common Stock Sale -$54.8K -603 -0.19% $90.88* 325K Nov 5, 2021 Direct F1, F3
transaction CDLX Common Stock Sale -$73.8K -800 -0.25% $92.26* 324K Nov 5, 2021 Direct F1, F4
transaction CDLX Common Stock Sale -$84.7K -911 -0.28% $92.95* 323K Nov 5, 2021 Direct F1, F5
holding CDLX Common Stock 14.6K Nov 5, 2021 See Footnote F6
holding CDLX Common Stock 14.6K Nov 5, 2021 See Footnote F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for performance stock units that vested on October 6, 2021.
F2 The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $89.52 to $90.49, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3), (4) and (5) to this Form 4.
F3 The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $90.54 to $91.39, inclusive.
F4 The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $91.85 to $92.79, inclusive.
F5 The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $92.90 to $93.00, inclusive.
F6 The reportable securities are held by the 2013 Lynne Marie Laube GRAT fbo Keegan George Allbright.
F7 The reportable securities are held by the 2013 Lynne Marie Laube GRAT fbo Hayley Marie Allbright.